Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edetate Calcium Disodium Challenge for Gadolinium Retention
NCT02421029Phase 4Withdrawn
- Sponsor
- Mount Sinai Medical Center
- Start
- Jul 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of edetate calcium disodium in Gadolinium retention, sponsored by Mount Sinai Medical Center. Planned start Jul 2017; status: withdrawn.
02
Drugs
edetate calcium disodium
03
Conditions
Gadolinium retention
Beyond the preview
Go deeper on NCT02421029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02421029.